Coronavirus Strategies to Boost Community Coronavirus Strategies to Boost Community


Nearly half of those surveyed doubt vaccine safety

Analysis by Dr. Joseph Mercola Fact Checked

doubts about vaccine safety

Story at-a-glance -

  • In an online survey of more than 2,000 U.S. adults, conducted on behalf of the American Osteopathic Association, 45% said they had doubts about vaccine safety
  • Online articles, past secrets and wrongdoing by the pharmaceutical industry and information from medical experts were noted as top reasons for doubting vaccine safety
  • Six percent of respondents agreed with the statement, “I think the risks of vaccine side effects outweigh the potential benefits of vaccination”
  • The CDC states, “Vaccines are tested to ensure that they are safe and effective for children to receive at the recommended ages,” but children and adults do not all respond the same way to vaccination
  • The ability to make informed, voluntary vaccine choices for yourself and your children must be protected, because vaccines are not a one-size-fits-all-solution, nor is the U.S. public as a whole a one-size-fits-all population

Every vaccine comes with a risk of adverse reactions, including death, and those risks can be greater for some people. It's up to each person to decide if the potential risks outweigh the potential benefits of the vaccination.

In the U.S., the CDC now recommends that children receive 69 doses of 16 vaccines by the time they're 18 years old, with 50 doses of 14 vaccines given before the age of 6. Adults are also being pressured by public health officials and doctors to get an annual flu shot and other vaccinations.

Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access